The US is investigating its funding of biolabs in over 30 countries, with reports suggesting the number of labs may be more than 120. The investigation appears to be focused on safety concerns and the use of taxpayer funds. However, there is some uncertainty about the details of the biolabs and the investigation, with conflicting reports and concerns about the accuracy of the information being released.